The trademark application ACELABIO was filed by ACELABIO (US) INC., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 30, 2021, and it was registered by office on September 6, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
Conducting research in support of human clinical trials, which may include analysis of biospecimens from pre-clinical or animal testing
Analysis of biospecimens at the protein, DNA or RNA level for discovery and/or development of disease activity measures or biomarkers
Histopathology based testing services
Histopathology support services, namely, reviewing and scoring tissue sample images provided by others
Processing of biopsy tissue to allow for blocking and sectioning with preparation and staining of glass slides
Preparing and staining glass slides for scientific and medical research purposes
Converting glass slides to digital slides, and analyzing digital slides for scientific and medical research purposes.